$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
CREXONT Extended-Release Capsules: New Data Demonstrate Significant Improvement in Sleep Quality in Parkinson's Disease Patients
2026-02-01 22:25:32
Check Details
Instructions for use of the new GnRH antagonist Linzagolix in the treatment of patients with uterine fibroids
2026-02-01 22:25:32
Check Details
Instructions for use of Atrasentan in patients with IgA nephropathy
2026-02-01 22:25:32
Check Details
What is the Chinese name of Guanfacine?
2026-02-01 22:25:32
Check Details
Do I need to take Bitovil/Bikonprofen tablets on time every day? Medication timing and compliance recommendations
2026-02-01 22:25:32
Check Details
An in-depth interpretation of the instructions for deuterated colexitinib
2026-02-01 22:25:32
Check Details
The price of Apremilast/Apremilast tablets revealed: How much does a box cost?
2026-02-01 22:25:32
Check Details
Can't I stop taking Valganciclovir once I take it? Discontinuation precautions and risks
2026-02-01 22:25:32
Check Details
Detailed explanation of the instructions for the antihypertensive drug Aprecitentan: from indications, treatment effects to medication precautions
2026-02-01 22:25:32
Check Details
Why is Guanfacine not recommended?
2026-02-01 22:25:32
Check Details
SURMOUNT-1 trial finds tilsiparatide/tilpotide supports long-term weight control
2026-02-01 22:25:32
Check Details
Is Pitobrutinib/Pitobrutinib launched in China? The latest news is here!
2026-02-01 22:25:32
Check Details
1
2
...
1460
1461
1462
1463
1464
1465
1466
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
New Research Progress on Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Tumor Relationship
2
Tyrosine Kinase and JAK Inhibitors May Increase Keratinocyte Carcinoma Risk: New Research Reveals Drug Safety Findings
3
CLISGen Database: A New Tool for Cell Line Selection in Cancer Genetic Variation Research
4
RAS Targeted Therapy Resistance Breakthrough: mTORC1 is Key, Dalifarnib Combination Therapy Brings Hope
5
ARID1A Gene: A New Breakthrough in Tumor Immunotherapy, Turning "Cold Tumors" Hot
6
User Agreement
7
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
8
What is the most important information I should know about WELIREG?
9
How to take and store WELIREG
10
How to take TRUSELTIQ correctly
11
How to deal with LONSURF side effects (1)
12
How to deal with LONSURF side effects (2)